In November 1994 after 15 years of epidemiologic silence, Ebola virus reeme
rged in Africa and, for the first time, in West Africa. In Cote d'Ivoire, a
34-year-old female ethologist was infected while conducting a necropsy on
a wild chimpanzee. Eight days later, the patient developed a syndrome that
did not respond to antimalarial drugs and was characterized by high fever,
headache, chills, myalgia, and cough. The patient had abdominal pain. diarr
hea, vomiting, and a macular rash, and was repatriated to Switzerland. The
patient suffered from prostration and weight loss but recovered without seq
uelae. Laboratory findings included aspartate aminotransferase and alanine
aminotransferase activity highly elevated, thrombocytopenia, lymphopenia, a
nd, subsequently, neutrophilia. A new subtype of Ebola was isolated from th
e patient's blood on days 4 and 8. No serologic conversion was detected amo
ng contact persons in Cote d'Ivoire (n = 22) or Switzerland (n = 52), sugge
sting that infection-control precautions were satisfactory.